PEOPLE - Enzo Biochem makes appointment:
This article was originally published in Clinica
Enzo Biochem has named Marcus Conant, a professor at the University of California Medical Center, to its board of directors. Mr Conant's appointment at the Farmingdale, New York-based biotechnology company, which specialises in genetic and immune regulation technologies for diagnostic and therapeutic applications, brings the number of board members to eight.
You may also be interested in...ï»¿
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.
The two companies announced more details about their COVID-19 vaccine development plan, including a $185m upfront payment and $113m equity investment from Pfizer.